The post UCLA leads research to study female health across the animal kingdom–providing insights for a myriad of female health conditions appeared first on Life Sciences.
[…]
The post Pregnant moms and depression: UCLA study links rising symptoms to kids’ behavioral issues appeared first on Life Sciences.
[…]
LOS ANGELES, May 31, 2022 /PRNewswire/ — Discovery Behavioral Health, Inc., an expanding network of evidence-based mental health, substance use and eating disorder treatment centers, has appointed Matthew Ruble, M.D., a Harvard-trained psychiatrist, a… […]
Funding will be directed to TLI’s Institute of Respiratory Medicine and Exercise Physiology with a Research Focus on Diverse and Underserved Patient Populations LOS ANGELES, May 31, 2022 /PRNewswire/ — The Lundquist Institute today announced that it h… […]
RANCHO CUCAMONGA, Calif., May 31, 2022 /PRNewswire/ — Amidst a national youth behavioral health crisis, Inland Empire Health Plan (IEHP) is partnering with Molina Healthcare, County Behavioral Health, the Offices of Education in Riverside and San Bern… […]
Roundtable Led by HFC and Caring Across Generations Invites Others to Start Conversations with Loved Ones about Caregiving LOS ANGELES, May 31, 2022 /PRNewswire/ — Leading Alzheimer’s and caregiving advocates HFC and Caring Across Generations today re… […]
LOS ANGELES, May 31, 2022 /PRNewswire/ — Leading hair wellness brand, VEGAMOUR, announces strategic partnership with celebrity and wellness enthusiast Nicole Kidman that sees her join the company as both an investor and brand advocate. This unique par… […]
LOS ANGELES, May 31, 2022 /PRNewswire/ — Athos Therapeutics, Inc. (the “Company”), a late-stage preclinical biotech company using artificial intelligence to develop small molecule therapeutics for immune-mediated diseases and cancer, announced today t… […]
SANTA BARBARA, Calif. , May 31, 2022 /PRNewswire/ — Reset Summer Camp for Digital Detox & Life Skills has a few spots left for this summer’s program in Santa Barbara, CA. Founded in 2018, Reset is the first of its kind, offering a clinical, therapeuti… […]
A small biotech trying to develop an Avastin biosimilar to treat wet AMD has run into a setback. Outlook Therapeutics withdrew its BLA for bevacizumab, the active compound in Roche/Genentech’s Avastin cancer therapy, after the FDA requested additional … […]
Copyright © 2021 Biotech Networks, LLC
